| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Predisposition to Disease | 261 | 2024 | 17897 | 5.560 |
Why?
|
| Genome-Wide Association Study | 194 | 2024 | 12676 | 4.830 |
Why?
|
| Genetic Variation | 115 | 2024 | 6567 | 4.630 |
Why?
|
| Polymorphism, Single Nucleotide | 239 | 2024 | 15920 | 4.140 |
Why?
|
| Genome, Human | 96 | 2024 | 4423 | 3.420 |
Why?
|
| Genetics, Population | 32 | 2024 | 935 | 3.230 |
Why?
|
| Crohn Disease | 60 | 2024 | 2278 | 3.160 |
Why?
|
| Haplotypes | 78 | 2023 | 2715 | 2.970 |
Why?
|
| Multifactorial Inheritance | 35 | 2024 | 1387 | 2.820 |
Why?
|
| Mutation, Missense | 38 | 2024 | 2567 | 2.270 |
Why?
|
| Chromosome Mapping | 87 | 2024 | 4612 | 2.050 |
Why?
|
| Linkage Disequilibrium | 58 | 2024 | 1994 | 1.900 |
Why?
|
| Inflammatory Bowel Diseases | 33 | 2023 | 2421 | 1.810 |
Why?
|
| Models, Genetic | 45 | 2024 | 3430 | 1.730 |
Why?
|
| Schizophrenia | 43 | 2024 | 6930 | 1.650 |
Why?
|
| Finland | 42 | 2024 | 607 | 1.630 |
Why?
|
| Child Development Disorders, Pervasive | 13 | 2015 | 600 | 1.630 |
Why?
|
| Macular Degeneration | 22 | 2023 | 1009 | 1.570 |
Why?
|
| Gene Frequency | 64 | 2024 | 3603 | 1.570 |
Why?
|
| Genotype | 112 | 2024 | 12985 | 1.430 |
Why?
|
| Disease | 13 | 2023 | 670 | 1.430 |
Why?
|
| Quantitative Trait Loci | 32 | 2024 | 2113 | 1.400 |
Why?
|
| Genetic Linkage | 52 | 2016 | 2340 | 1.350 |
Why?
|
| Colitis, Ulcerative | 35 | 2023 | 1920 | 1.340 |
Why?
|
| Sequence Analysis, DNA | 42 | 2023 | 4739 | 1.330 |
Why?
|
| Genetic Loci | 30 | 2024 | 2623 | 1.320 |
Why?
|
| Genetic Association Studies | 33 | 2024 | 2731 | 1.320 |
Why?
|
| Mutation | 68 | 2024 | 30004 | 1.240 |
Why?
|
| Jews | 15 | 2023 | 356 | 1.240 |
Why?
|
| Phenotype | 97 | 2024 | 16575 | 1.230 |
Why?
|
| Genetic Markers | 42 | 2020 | 2599 | 1.230 |
Why?
|
| Genetics, Medical | 9 | 2020 | 334 | 1.190 |
Why?
|
| DNA Copy Number Variations | 20 | 2023 | 2024 | 1.190 |
Why?
|
| Genome | 24 | 2022 | 1738 | 1.170 |
Why?
|
| Case-Control Studies | 111 | 2024 | 22174 | 1.160 |
Why?
|
| Alleles | 72 | 2024 | 6857 | 1.130 |
Why?
|
| Epilepsy, Generalized | 3 | 2024 | 178 | 1.080 |
Why?
|
| Complement Factor H | 8 | 2023 | 110 | 1.040 |
Why?
|
| Mice, Inbred Strains | 11 | 2010 | 1762 | 1.010 |
Why?
|
| Humans | 623 | 2024 | 761222 | 1.010 |
Why?
|
| Awards and Prizes | 3 | 2019 | 362 | 1.000 |
Why?
|
| Software | 34 | 2023 | 4431 | 0.990 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 18 | 2023 | 3707 | 0.900 |
Why?
|
| Genomics | 26 | 2024 | 5829 | 0.900 |
Why?
|
| Autistic Disorder | 11 | 2023 | 1222 | 0.820 |
Why?
|
| Germ-Line Mutation | 13 | 2024 | 1852 | 0.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 44 | 2024 | 12159 | 0.820 |
Why?
|
| Multigene Family | 8 | 2020 | 1075 | 0.810 |
Why?
|
| Gene Deletion | 7 | 2017 | 2658 | 0.800 |
Why?
|
| Quantitative Trait, Heritable | 15 | 2019 | 540 | 0.800 |
Why?
|
| Biological Specimen Banks | 12 | 2024 | 780 | 0.790 |
Why?
|
| Heterozygote | 31 | 2024 | 2778 | 0.770 |
Why?
|
| Genetic Diseases, Inborn | 10 | 2021 | 603 | 0.770 |
Why?
|
| Pedigree | 48 | 2021 | 4537 | 0.760 |
Why?
|
| Intestinal Neoplasms | 1 | 2023 | 315 | 0.720 |
Why?
|
| Exons | 17 | 2020 | 2380 | 0.690 |
Why?
|
| Databases, Genetic | 18 | 2024 | 1741 | 0.690 |
Why?
|
| Computational Biology | 19 | 2020 | 3499 | 0.670 |
Why?
|
| Homozygote | 24 | 2024 | 1775 | 0.670 |
Why?
|
| RNA Splice Sites | 4 | 2018 | 210 | 0.670 |
Why?
|
| Databases, Nucleic Acid | 6 | 2018 | 205 | 0.650 |
Why?
|
| Genes, Recessive | 5 | 2023 | 622 | 0.620 |
Why?
|
| Proteins | 17 | 2023 | 5993 | 0.610 |
Why?
|
| Female | 295 | 2024 | 392552 | 0.610 |
Why?
|
| Male | 264 | 2024 | 360703 | 0.600 |
Why?
|
| Minisatellite Repeats | 4 | 2013 | 163 | 0.590 |
Why?
|
| Calcium Channels | 2 | 2020 | 620 | 0.590 |
Why?
|
| Epilepsies, Partial | 4 | 2024 | 431 | 0.580 |
Why?
|
| RNA Splicing | 4 | 2018 | 896 | 0.580 |
Why?
|
| Major Histocompatibility Complex | 12 | 2021 | 872 | 0.580 |
Why?
|
| Polymorphism, Genetic | 30 | 2018 | 4243 | 0.570 |
Why?
|
| Founder Effect | 9 | 2014 | 185 | 0.560 |
Why?
|
| Bipolar Disorder | 18 | 2023 | 5092 | 0.550 |
Why?
|
| Neuroendocrine Tumors | 1 | 2023 | 642 | 0.550 |
Why?
|
| Chromosomes, Human, X | 5 | 2024 | 320 | 0.540 |
Why?
|
| Cation Transport Proteins | 4 | 2020 | 324 | 0.540 |
Why?
|
| Alternative Splicing | 4 | 2018 | 1087 | 0.540 |
Why?
|
| Mental Disorders | 13 | 2020 | 6823 | 0.530 |
Why?
|
| Meta-Analysis as Topic | 12 | 2023 | 1381 | 0.520 |
Why?
|
| Algorithms | 28 | 2024 | 14025 | 0.520 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1075 | 0.520 |
Why?
|
| Nucleotides | 2 | 2018 | 452 | 0.510 |
Why?
|
| Sequence Deletion | 12 | 2020 | 1487 | 0.510 |
Why?
|
| Carrier Proteins | 22 | 2023 | 4935 | 0.500 |
Why?
|
| High-Throughput Nucleotide Sequencing | 15 | 2024 | 3634 | 0.500 |
Why?
|
| Base Sequence | 39 | 2016 | 12404 | 0.500 |
Why?
|
| Seizures | 3 | 2024 | 2965 | 0.490 |
Why?
|
| Autoimmune Diseases | 9 | 2024 | 2244 | 0.490 |
Why?
|
| Gene Expression Regulation | 24 | 2023 | 11855 | 0.490 |
Why?
|
| Group II Chaperonins | 1 | 2014 | 7 | 0.490 |
Why?
|
| Genetic Testing | 21 | 2023 | 3537 | 0.480 |
Why?
|
| Receptors, Interleukin | 5 | 2024 | 242 | 0.480 |
Why?
|
| Gene Regulatory Networks | 5 | 2018 | 1743 | 0.480 |
Why?
|
| DNA Mutational Analysis | 21 | 2021 | 4107 | 0.470 |
Why?
|
| Rare Diseases | 3 | 2020 | 624 | 0.460 |
Why?
|
| Risk Factors | 81 | 2024 | 74241 | 0.450 |
Why?
|
| Genes | 5 | 2017 | 1820 | 0.450 |
Why?
|
| Genes, Essential | 3 | 2020 | 185 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 5 | 11 | 2009 | 386 | 0.440 |
Why?
|
| Membrane Proteins | 19 | 2020 | 7851 | 0.430 |
Why?
|
| Gram-Positive Cocci | 4 | 2000 | 8 | 0.420 |
Why?
|
| Ubiquitin-Protein Ligases | 7 | 2019 | 1892 | 0.420 |
Why?
|
| Lod Score | 26 | 2014 | 600 | 0.410 |
Why?
|
| DiGeorge Syndrome | 3 | 2022 | 185 | 0.410 |
Why?
|
| Calcium Channels, L-Type | 2 | 2011 | 241 | 0.410 |
Why?
|
| Penetrance | 5 | 2020 | 382 | 0.410 |
Why?
|
| Developmental Disabilities | 3 | 2020 | 1510 | 0.400 |
Why?
|
| Gene Dosage | 10 | 2016 | 1217 | 0.400 |
Why?
|
| Chromosomes, Human | 9 | 2020 | 442 | 0.400 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.400 |
Why?
|
| Selection, Genetic | 9 | 2023 | 871 | 0.390 |
Why?
|
| Loss of Heterozygosity | 2 | 2013 | 662 | 0.390 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 167 | 0.390 |
Why?
|
| Adult | 127 | 2024 | 221120 | 0.380 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 20 | 2015 | 3777 | 0.380 |
Why?
|
| Microsatellite Repeats | 16 | 2015 | 782 | 0.370 |
Why?
|
| Phylogeny | 10 | 2022 | 2809 | 0.370 |
Why?
|
| Manganese | 3 | 2020 | 391 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 12 | 10 | 2009 | 430 | 0.370 |
Why?
|
| Epilepsy | 7 | 2024 | 3304 | 0.370 |
Why?
|
| Complement C3b Inactivator Proteins | 1 | 2010 | 13 | 0.360 |
Why?
|
| CARD Signaling Adaptor Proteins | 4 | 2017 | 159 | 0.360 |
Why?
|
| Demography | 4 | 2020 | 1641 | 0.360 |
Why?
|
| Human Genome Project | 6 | 2024 | 200 | 0.350 |
Why?
|
| DNA-Binding Proteins | 13 | 2016 | 9567 | 0.350 |
Why?
|
| Chromosomes, Mammalian | 7 | 2022 | 147 | 0.340 |
Why?
|
| Multiple Sclerosis | 13 | 2015 | 3222 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 6 | 8 | 2009 | 368 | 0.340 |
Why?
|
| HLA-A Antigens | 4 | 2019 | 223 | 0.340 |
Why?
|
| Radioactive Waste | 2 | 2000 | 8 | 0.340 |
Why?
|
| Salmonella Infections | 3 | 2016 | 172 | 0.340 |
Why?
|
| Sequence Alignment | 8 | 2014 | 2175 | 0.340 |
Why?
|
| Nuclear Proteins | 9 | 2023 | 5783 | 0.340 |
Why?
|
| Animals | 99 | 2024 | 168089 | 0.330 |
Why?
|
| Allelic Imbalance | 3 | 2019 | 77 | 0.330 |
Why?
|
| DNA | 14 | 2023 | 7189 | 0.330 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2023 | 1249 | 0.320 |
Why?
|
| Computer Simulation | 22 | 2024 | 6224 | 0.320 |
Why?
|
| Transcription Factors | 22 | 2021 | 12101 | 0.320 |
Why?
|
| Cohort Studies | 50 | 2024 | 41496 | 0.320 |
Why?
|
| Complement Factor I | 3 | 2015 | 14 | 0.320 |
Why?
|
| HLA Antigens | 7 | 2021 | 1331 | 0.320 |
Why?
|
| Mice | 65 | 2024 | 81330 | 0.320 |
Why?
|
| Micrococcus | 2 | 1999 | 13 | 0.310 |
Why?
|
| Genetic Pleiotropy | 5 | 2021 | 181 | 0.310 |
Why?
|
| Population Groups | 4 | 2010 | 207 | 0.310 |
Why?
|
| Middle Aged | 116 | 2024 | 220858 | 0.310 |
Why?
|
| Mucin-1 | 1 | 2013 | 538 | 0.300 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2021 | 1360 | 0.300 |
Why?
|
| Genetic Techniques | 2 | 2008 | 428 | 0.300 |
Why?
|
| Membrane Glycoproteins | 6 | 2012 | 3696 | 0.300 |
Why?
|
| Cytokine Receptor Common beta Subunit | 2 | 2019 | 22 | 0.300 |
Why?
|
| Open Reading Frames | 6 | 2018 | 811 | 0.290 |
Why?
|
| Glaucoma | 3 | 2023 | 1186 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 2 | 6 | 2016 | 313 | 0.290 |
Why?
|
| Molecular Sequence Data | 40 | 2014 | 17598 | 0.290 |
Why?
|
| Population | 3 | 2017 | 141 | 0.280 |
Why?
|
| Genetic Drift | 2 | 2019 | 41 | 0.280 |
Why?
|
| Amino Acid Substitution | 10 | 2020 | 1737 | 0.280 |
Why?
|
| Blood Proteins | 2 | 2024 | 1173 | 0.280 |
Why?
|
| Intestines | 6 | 2021 | 1908 | 0.280 |
Why?
|
| Autophagy | 9 | 2018 | 1327 | 0.280 |
Why?
|
| Arthritis, Rheumatoid | 8 | 2019 | 3753 | 0.270 |
Why?
|
| Clozapine | 2 | 2024 | 504 | 0.270 |
Why?
|
| Geography | 6 | 2021 | 652 | 0.270 |
Why?
|
| Chromosome Aberrations | 6 | 2021 | 1767 | 0.270 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 1408 | 0.270 |
Why?
|
| Genetic Heterogeneity | 8 | 2024 | 734 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 8 | 5 | 2019 | 452 | 0.260 |
Why?
|
| Sialyltransferases | 3 | 2018 | 83 | 0.260 |
Why?
|
| Data Interpretation, Statistical | 5 | 2011 | 2691 | 0.260 |
Why?
|
| Evolution, Molecular | 7 | 2022 | 1882 | 0.260 |
Why?
|
| Models, Statistical | 8 | 2015 | 5081 | 0.260 |
Why?
|
| Codon, Nonsense | 3 | 2019 | 284 | 0.260 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2023 | 739 | 0.260 |
Why?
|
| Inheritance Patterns | 6 | 2015 | 341 | 0.250 |
Why?
|
| User-Computer Interface | 4 | 2019 | 1393 | 0.250 |
Why?
|
| Reproducibility of Results | 28 | 2022 | 20118 | 0.250 |
Why?
|
| Lactoferrin | 1 | 2006 | 100 | 0.250 |
Why?
|
| Mitochondrial Proteins | 4 | 2020 | 974 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 8 | 2021 | 4404 | 0.250 |
Why?
|
| Family | 16 | 2020 | 3192 | 0.250 |
Why?
|
| Psychotic Disorders | 5 | 2024 | 3220 | 0.240 |
Why?
|
| Genetic Structures | 2 | 2022 | 12 | 0.240 |
Why?
|
| Cholesterol, HDL | 7 | 2013 | 1812 | 0.240 |
Why?
|
| Physical Chromosome Mapping | 7 | 2020 | 183 | 0.240 |
Why?
|
| Denmark | 7 | 2020 | 770 | 0.240 |
Why?
|
| Aging | 8 | 2024 | 8702 | 0.240 |
Why?
|
| Synteny | 3 | 2022 | 77 | 0.240 |
Why?
|
| Mosaicism | 3 | 2024 | 477 | 0.240 |
Why?
|
| Child | 51 | 2024 | 80154 | 0.240 |
Why?
|
| Longevity | 6 | 2020 | 1063 | 0.240 |
Why?
|
| Cardiovascular Diseases | 10 | 2023 | 15521 | 0.240 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2019 | 890 | 0.230 |
Why?
|
| Chromosomes | 6 | 2023 | 579 | 0.230 |
Why?
|
| Ileus | 1 | 2024 | 66 | 0.230 |
Why?
|
| Myosin Type II | 1 | 2024 | 70 | 0.230 |
Why?
|
| Colitis | 4 | 2024 | 1234 | 0.230 |
Why?
|
| Molecular Epidemiology | 4 | 2022 | 470 | 0.230 |
Why?
|
| Factor V | 2 | 2024 | 168 | 0.230 |
Why?
|
| Trout | 1 | 2023 | 20 | 0.230 |
Why?
|
| Weight Loss | 3 | 2013 | 2680 | 0.230 |
Why?
|
| Inbreeding | 2 | 2022 | 48 | 0.230 |
Why?
|
| Ixodes | 1 | 2024 | 40 | 0.230 |
Why?
|
| Serine Endopeptidases | 4 | 2021 | 1022 | 0.230 |
Why?
|
| Consanguinity | 7 | 2020 | 457 | 0.230 |
Why?
|
| Recombination, Genetic | 8 | 2009 | 1518 | 0.220 |
Why?
|
| Insulin | 9 | 2017 | 6588 | 0.220 |
Why?
|
| Heteroptera | 1 | 2023 | 3 | 0.220 |
Why?
|
| Internet | 7 | 2020 | 3096 | 0.220 |
Why?
|
| Raynaud Disease | 1 | 2024 | 79 | 0.220 |
Why?
|
| Prothrombin | 1 | 2024 | 192 | 0.220 |
Why?
|
| Coronary Artery Disease | 7 | 2023 | 6506 | 0.220 |
Why?
|
| Postprandial Period | 2 | 2017 | 314 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 10 | 5 | 2021 | 277 | 0.220 |
Why?
|
| Lichen Planus, Oral | 1 | 2024 | 57 | 0.220 |
Why?
|
| Pyrophosphatases | 2 | 2019 | 142 | 0.220 |
Why?
|
| Genes, BRCA1 | 5 | 2009 | 754 | 0.220 |
Why?
|
| Intestinal Mucosa | 7 | 2024 | 3031 | 0.220 |
Why?
|
| HLA-B Antigens | 3 | 2019 | 317 | 0.220 |
Why?
|
| Organizational Policy | 1 | 2006 | 431 | 0.220 |
Why?
|
| Migraine without Aura | 2 | 2018 | 82 | 0.220 |
Why?
|
| Epithelial Cells | 6 | 2024 | 3671 | 0.210 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6223 | 0.210 |
Why?
|
| Africa | 4 | 2021 | 714 | 0.210 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2023 | 27 | 0.210 |
Why?
|
| Transcription, Genetic | 7 | 2020 | 7571 | 0.210 |
Why?
|
| Lipase | 4 | 2018 | 320 | 0.210 |
Why?
|
| Genome, Bacterial | 4 | 2001 | 785 | 0.210 |
Why?
|
| Lipids | 5 | 2021 | 3331 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2013 | 361 | 0.210 |
Why?
|
| Aged | 75 | 2024 | 169292 | 0.210 |
Why?
|
| Cattle | 2 | 2022 | 3818 | 0.210 |
Why?
|
| Odds Ratio | 17 | 2018 | 9652 | 0.210 |
Why?
|
| Likelihood Functions | 7 | 2014 | 991 | 0.200 |
Why?
|
| Sequence Homology | 2 | 2020 | 196 | 0.200 |
Why?
|
| Breast Neoplasms | 22 | 2020 | 20982 | 0.200 |
Why?
|
| Alzheimer Disease | 6 | 2018 | 8606 | 0.200 |
Why?
|
| Attitude to Health | 3 | 2008 | 2026 | 0.200 |
Why?
|
| Protein Conformation | 6 | 2020 | 3933 | 0.200 |
Why?
|
| Point Mutation | 6 | 2015 | 1593 | 0.200 |
Why?
|
| Emigration and Immigration | 2 | 2020 | 397 | 0.200 |
Why?
|
| Mendelian Randomization Analysis | 5 | 2024 | 1010 | 0.200 |
Why?
|
| Borrelia burgdorferi | 1 | 2024 | 183 | 0.200 |
Why?
|
| Phosphoproteins | 5 | 2018 | 2444 | 0.200 |
Why?
|
| Interferon Regulatory Factors | 3 | 2009 | 261 | 0.200 |
Why?
|
| Age of Onset | 13 | 2020 | 3307 | 0.200 |
Why?
|
| Adolescent | 45 | 2024 | 88300 | 0.190 |
Why?
|
| Community Health Nursing | 1 | 2001 | 23 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 16 | 4 | 2015 | 343 | 0.190 |
Why?
|
| Pharyngeal Diseases | 1 | 2023 | 134 | 0.190 |
Why?
|
| Biostatistics | 2 | 2020 | 164 | 0.190 |
Why?
|
| Otosclerosis | 1 | 2023 | 113 | 0.190 |
Why?
|
| Pouchitis | 1 | 2022 | 64 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 107 | 0.190 |
Why?
|
| RNA, Messenger | 15 | 2022 | 12747 | 0.190 |
Why?
|
| Chromosomes, Bacterial | 5 | 2001 | 280 | 0.190 |
Why?
|
| INDEL Mutation | 3 | 2018 | 265 | 0.190 |
Why?
|
| Molecular Sequence Annotation | 3 | 2020 | 518 | 0.190 |
Why?
|
| Low Tension Glaucoma | 1 | 2021 | 24 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2022 | 2871 | 0.190 |
Why?
|
| Antithrombin III | 3 | 1996 | 128 | 0.190 |
Why?
|
| Nuclear Family | 9 | 2007 | 311 | 0.190 |
Why?
|
| Obesity | 9 | 2020 | 12940 | 0.190 |
Why?
|
| History, 21st Century | 3 | 2018 | 1567 | 0.190 |
Why?
|
| Myosins | 3 | 2009 | 404 | 0.190 |
Why?
|
| Pneumonia | 2 | 2024 | 2142 | 0.190 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2021 | 44 | 0.180 |
Why?
|
| Radiology Information Systems | 3 | 2011 | 529 | 0.180 |
Why?
|
| Neoplasms | 9 | 2020 | 22142 | 0.180 |
Why?
|
| Oxidoreductases | 2 | 2020 | 411 | 0.180 |
Why?
|
| Pre-Eclampsia | 2 | 2023 | 1233 | 0.180 |
Why?
|
| Migraine Disorders | 5 | 2018 | 1701 | 0.180 |
Why?
|
| Risk | 17 | 2020 | 9616 | 0.180 |
Why?
|
| Dyslipidemias | 2 | 2021 | 870 | 0.180 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 1342 | 0.180 |
Why?
|
| Sample Size | 8 | 2020 | 843 | 0.180 |
Why?
|
| Clone Cells | 1 | 2024 | 1668 | 0.180 |
Why?
|
| Geographic Atrophy | 2 | 2012 | 91 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2011 | 534 | 0.180 |
Why?
|
| Aneuploidy | 1 | 2024 | 555 | 0.180 |
Why?
|
| Postpartum Hemorrhage | 1 | 2024 | 272 | 0.180 |
Why?
|
| Brain | 16 | 2023 | 27094 | 0.180 |
Why?
|
| Gene Expression | 10 | 2018 | 7571 | 0.180 |
Why?
|
| Complement C3 | 3 | 2013 | 434 | 0.180 |
Why?
|
| Professional Autonomy | 1 | 2001 | 171 | 0.180 |
Why?
|
| Exfoliation Syndrome | 1 | 2021 | 113 | 0.170 |
Why?
|
| Parturition | 2 | 2018 | 447 | 0.170 |
Why?
|
| Peptide Hormones | 1 | 2021 | 132 | 0.170 |
Why?
|
| Lymphocytes | 6 | 2020 | 2603 | 0.170 |
Why?
|
| Amino Acid Sequence | 20 | 2020 | 13402 | 0.170 |
Why?
|
| Safety Management | 1 | 2006 | 761 | 0.170 |
Why?
|
| Nurse's Role | 1 | 2001 | 188 | 0.170 |
Why?
|
| Waste Management | 1 | 2000 | 19 | 0.170 |
Why?
|
| Antithrombin III Deficiency | 2 | 1998 | 28 | 0.170 |
Why?
|
| Repressor Proteins | 6 | 2020 | 2974 | 0.170 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2014 | 182 | 0.170 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2021 | 570 | 0.170 |
Why?
|
| Ocular Hypertension | 1 | 2021 | 208 | 0.170 |
Why?
|
| Protein Isoforms | 5 | 2018 | 1695 | 0.170 |
Why?
|
| Respiration Disorders | 1 | 2023 | 366 | 0.170 |
Why?
|
| Cell Line | 14 | 2022 | 15545 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 3 | 2020 | 1448 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2012 | 2803 | 0.170 |
Why?
|
| Fasting | 6 | 2017 | 1603 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2008 | 2157 | 0.170 |
Why?
|
| History, 20th Century | 3 | 2018 | 2765 | 0.160 |
Why?
|
| BRCA2 Protein | 7 | 2011 | 797 | 0.160 |
Why?
|
| Registries | 8 | 2024 | 8246 | 0.160 |
Why?
|
| Blood Glucose | 7 | 2011 | 6392 | 0.160 |
Why?
|
| Sequence Tagged Sites | 4 | 2006 | 96 | 0.160 |
Why?
|
| Hernia, Inguinal | 1 | 2022 | 220 | 0.160 |
Why?
|
| Cholesterol, LDL | 6 | 2020 | 2380 | 0.160 |
Why?
|
| Proteomics | 4 | 2024 | 3840 | 0.160 |
Why?
|
| Leukocytes | 3 | 2024 | 2025 | 0.160 |
Why?
|
| Triglycerides | 5 | 2021 | 2457 | 0.160 |
Why?
|
| Chromosome Deletion | 7 | 2015 | 1386 | 0.160 |
Why?
|
| Paternal Age | 1 | 2019 | 87 | 0.160 |
Why?
|
| Apolipoprotein E4 | 1 | 2023 | 709 | 0.160 |
Why?
|
| Interleukins | 2 | 2017 | 782 | 0.160 |
Why?
|
| Genes, BRCA2 | 3 | 2009 | 591 | 0.160 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2021 | 176 | 0.160 |
Why?
|
| Radioactive Pollutants | 1 | 1998 | 13 | 0.160 |
Why?
|
| Proton-Translocating ATPases | 1 | 2019 | 112 | 0.160 |
Why?
|
| Europe | 10 | 2020 | 3423 | 0.160 |
Why?
|
| Mouth Neoplasms | 1 | 2024 | 596 | 0.160 |
Why?
|
| Insulin Resistance | 5 | 2017 | 3952 | 0.160 |
Why?
|
| Neurobiology | 1 | 2020 | 137 | 0.160 |
Why?
|
| Guanylate Cyclase | 2 | 2012 | 205 | 0.160 |
Why?
|
| Family Health | 8 | 2017 | 1254 | 0.160 |
Why?
|
| Infertility, Female | 1 | 2024 | 761 | 0.160 |
Why?
|
| Dietary Carbohydrates | 1 | 2003 | 891 | 0.160 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2024 | 832 | 0.160 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 114 | 0.150 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2019 | 1462 | 0.150 |
Why?
|
| Apolipoproteins E | 4 | 2018 | 1443 | 0.150 |
Why?
|
| Carbamazepine | 1 | 2019 | 224 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2009 | 638 | 0.150 |
Why?
|
| BRCA1 Protein | 7 | 2020 | 1149 | 0.150 |
Why?
|
| Thyrotropin | 2 | 2020 | 833 | 0.150 |
Why?
|
| Child, Preschool | 25 | 2024 | 42225 | 0.150 |
Why?
|
| Chromosome Duplication | 1 | 2018 | 75 | 0.150 |
Why?
|
| Haploinsufficiency | 1 | 2020 | 336 | 0.150 |
Why?
|
| Metabolic Diseases | 2 | 2020 | 680 | 0.150 |
Why?
|
| Heat-Shock Proteins | 2 | 2019 | 795 | 0.150 |
Why?
|
| Radiation Tolerance | 6 | 2000 | 478 | 0.150 |
Why?
|
| Gene Flow | 1 | 2018 | 78 | 0.150 |
Why?
|
| Biological Psychiatry | 1 | 2017 | 27 | 0.150 |
Why?
|
| Choroidal Neovascularization | 2 | 2012 | 364 | 0.150 |
Why?
|
| Young Adult | 21 | 2024 | 59222 | 0.150 |
Why?
|
| Lyme Disease | 1 | 2024 | 631 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 4 | 4 | 2008 | 375 | 0.150 |
Why?
|
| Immunity, Innate | 4 | 2013 | 3044 | 0.150 |
Why?
|
| Tourette Syndrome | 1 | 2021 | 395 | 0.150 |
Why?
|
| Longitudinal Studies | 7 | 2024 | 14610 | 0.150 |
Why?
|
| Adherens Junctions | 1 | 2018 | 90 | 0.140 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2024 | 614 | 0.140 |
Why?
|
| Population Density | 1 | 2018 | 193 | 0.140 |
Why?
|
| Smad3 Protein | 2 | 2017 | 166 | 0.140 |
Why?
|
| Intraocular Pressure | 2 | 2021 | 1294 | 0.140 |
Why?
|
| Adaptive Immunity | 2 | 2013 | 724 | 0.140 |
Why?
|
| Mesalamine | 1 | 2018 | 134 | 0.140 |
Why?
|
| Aortic Aneurysm | 1 | 2022 | 648 | 0.140 |
Why?
|
| Efficiency, Organizational | 3 | 2011 | 695 | 0.140 |
Why?
|
| Conserved Sequence | 7 | 2018 | 1162 | 0.140 |
Why?
|
| Mercury | 1 | 2000 | 289 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2015 | 1141 | 0.140 |
Why?
|
| Mammals | 1 | 2022 | 1129 | 0.140 |
Why?
|
| Chymotrypsin | 1 | 2016 | 137 | 0.140 |
Why?
|
| Nod2 Signaling Adaptor Protein | 3 | 2015 | 86 | 0.140 |
Why?
|
| Genetic Engineering | 2 | 2000 | 930 | 0.140 |
Why?
|
| Thromboembolism | 2 | 2020 | 992 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 20 | 2024 | 22128 | 0.140 |
Why?
|
| Antipsychotic Agents | 2 | 2024 | 3064 | 0.140 |
Why?
|
| Hexosyltransferases | 1 | 2016 | 58 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2020 | 4513 | 0.140 |
Why?
|
| Liver Failure, Acute | 1 | 2018 | 181 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 894 | 0.140 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2011 | 563 | 0.140 |
Why?
|
| Disease Susceptibility | 8 | 2019 | 1791 | 0.140 |
Why?
|
| Bruch Membrane | 1 | 2016 | 65 | 0.140 |
Why?
|
| Specialization | 1 | 2001 | 778 | 0.130 |
Why?
|
| Genetic Counseling | 3 | 1999 | 628 | 0.130 |
Why?
|
| Rec A Recombinases | 1 | 1996 | 50 | 0.130 |
Why?
|
| Sodium | 2 | 2020 | 1589 | 0.130 |
Why?
|
| Gene Rearrangement | 2 | 2012 | 1125 | 0.130 |
Why?
|
| Species Specificity | 6 | 2014 | 2406 | 0.130 |
Why?
|
| Body Height | 2 | 2019 | 1566 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1997 | 247 | 0.130 |
Why?
|
| Retinal Drusen | 1 | 2016 | 75 | 0.130 |
Why?
|
| Risk Assessment | 15 | 2023 | 24022 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2019 | 364 | 0.130 |
Why?
|
| Salmonella enterica | 1 | 2016 | 76 | 0.130 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 2 | 2019 | 134 | 0.130 |
Why?
|
| Genes, Lethal | 1 | 2016 | 223 | 0.130 |
Why?
|
| Celiac Disease | 4 | 2011 | 819 | 0.130 |
Why?
|
| Plasma | 1 | 2019 | 586 | 0.130 |
Why?
|
| Radiology Department, Hospital | 2 | 2011 | 407 | 0.130 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3788 | 0.130 |
Why?
|
| Poisson Distribution | 2 | 2020 | 504 | 0.130 |
Why?
|
| Gene Expression Profiling | 13 | 2019 | 9417 | 0.130 |
Why?
|
| Markov Chains | 3 | 2012 | 965 | 0.130 |
Why?
|
| Agranulocytosis | 2 | 2014 | 97 | 0.130 |
Why?
|
| Salmonella typhimurium | 2 | 2016 | 347 | 0.130 |
Why?
|
| Consensus Sequence | 2 | 2014 | 362 | 0.130 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 494 | 0.130 |
Why?
|
| Potassium Channels | 2 | 2012 | 537 | 0.130 |
Why?
|
| Migraine with Aura | 1 | 2018 | 204 | 0.130 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2018 | 179 | 0.130 |
Why?
|
| Ovarian Neoplasms | 10 | 2004 | 4872 | 0.130 |
Why?
|
| Receptors, Endothelin | 1 | 2015 | 56 | 0.130 |
Why?
|
| Candidiasis, Invasive | 1 | 2015 | 23 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2020 | 682 | 0.130 |
Why?
|
| Communication Disorders | 1 | 2016 | 50 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2019 | 1032 | 0.130 |
Why?
|
| Aged, 80 and over | 29 | 2024 | 58952 | 0.130 |
Why?
|
| DNA Transposable Elements | 1 | 1999 | 754 | 0.130 |
Why?
|
| Eye Neoplasms | 1 | 2017 | 307 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2009 | 1003 | 0.130 |
Why?
|
| Neutrophils | 2 | 2019 | 3763 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 7 | 5 | 2009 | 310 | 0.130 |
Why?
|
| Lectins, C-Type | 2 | 2017 | 585 | 0.130 |
Why?
|
| Heredity | 1 | 2016 | 148 | 0.130 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2022 | 695 | 0.130 |
Why?
|
| Ubiquitination | 3 | 2018 | 1005 | 0.130 |
Why?
|
| Skin Pigmentation | 1 | 2017 | 277 | 0.130 |
Why?
|
| Receptors, Mitogen | 1 | 2015 | 61 | 0.130 |
Why?
|
| Receptors, Angiotensin | 1 | 2015 | 140 | 0.130 |
Why?
|
| Frameshift Mutation | 2 | 2016 | 392 | 0.120 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2016 | 224 | 0.120 |
Why?
|
| Chromatin | 5 | 2017 | 2946 | 0.120 |
Why?
|
| Complement C4 | 1 | 2016 | 216 | 0.120 |
Why?
|
| Contactins | 1 | 2015 | 21 | 0.120 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2016 | 122 | 0.120 |
Why?
|
| Lysosomes | 2 | 2022 | 921 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 2756 | 0.120 |
Why?
|
| Research | 1 | 2024 | 1976 | 0.120 |
Why?
|
| Principal Component Analysis | 5 | 2019 | 942 | 0.120 |
Why?
|
| Zebrafish | 6 | 2019 | 3000 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2018 | 322 | 0.120 |
Why?
|
| Marijuana Abuse | 1 | 2019 | 410 | 0.120 |
Why?
|
| Genes, MHC Class I | 2 | 2016 | 235 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2020 | 2897 | 0.120 |
Why?
|
| Muscle Proteins | 3 | 2014 | 1149 | 0.120 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2014 | 13 | 0.120 |
Why?
|
| Molecular Chaperones | 1 | 2019 | 754 | 0.120 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 527 | 0.120 |
Why?
|
| Shaw Potassium Channels | 1 | 2014 | 20 | 0.120 |
Why?
|
| Cognition Disorders | 3 | 2014 | 3976 | 0.120 |
Why?
|
| Chromosome Breakage | 2 | 2012 | 159 | 0.120 |
Why?
|
| Prion Diseases | 1 | 2016 | 99 | 0.120 |
Why?
|
| Chaperonins | 1 | 2014 | 58 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 14 | 2011 | 6067 | 0.120 |
Why?
|
| Linear Models | 3 | 2020 | 5869 | 0.120 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 609 | 0.120 |
Why?
|
| GTP-Binding Proteins | 2 | 2009 | 946 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2004 | 410 | 0.120 |
Why?
|
| Genetic Code | 1 | 2014 | 138 | 0.110 |
Why?
|
| Myopathies, Nemaline | 1 | 2014 | 73 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2008 | 577 | 0.110 |
Why?
|
| Logistic Models | 9 | 2019 | 13249 | 0.110 |
Why?
|
| Complement C9 | 1 | 2013 | 15 | 0.110 |
Why?
|
| Neoplasm Proteins | 8 | 2011 | 3594 | 0.110 |
Why?
|
| Myofibrils | 1 | 2014 | 142 | 0.110 |
Why?
|
| Bayes Theorem | 5 | 2023 | 2329 | 0.110 |
Why?
|
| Regression Analysis | 6 | 2015 | 6345 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 1250 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2017 | 558 | 0.110 |
Why?
|
| Paneth Cells | 1 | 2014 | 98 | 0.110 |
Why?
|
| Societies, Scientific | 1 | 2015 | 223 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2020 | 789 | 0.110 |
Why?
|
| Myocardium | 6 | 2024 | 4746 | 0.110 |
Why?
|
| Gastric Bypass | 2 | 2013 | 818 | 0.110 |
Why?
|
| Hypertension | 5 | 2020 | 8536 | 0.110 |
Why?
|
| Nervous System Malformations | 1 | 2015 | 244 | 0.110 |
Why?
|
| Inflammation | 6 | 2024 | 10759 | 0.110 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2016 | 330 | 0.110 |
Why?
|
| HLA-DR Antigens | 4 | 2011 | 606 | 0.110 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2007 | 455 | 0.110 |
Why?
|
| Lipoprotein(a) | 1 | 2018 | 482 | 0.110 |
Why?
|
| Environment | 5 | 2012 | 1122 | 0.110 |
Why?
|
| Intelligence Tests | 1 | 2014 | 503 | 0.110 |
Why?
|
| Gamma Rays | 4 | 2011 | 318 | 0.110 |
Why?
|
| Stevens-Johnson Syndrome | 2 | 2019 | 246 | 0.110 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2013 | 73 | 0.110 |
Why?
|
| Calcium | 6 | 2006 | 5719 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 4340 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 5773 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 4 | 2018 | 346 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 4 | 2008 | 322 | 0.110 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2013 | 108 | 0.110 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2012 | 20 | 0.110 |
Why?
|
| Salmonella | 2 | 2015 | 125 | 0.110 |
Why?
|
| Heart | 4 | 2012 | 4431 | 0.110 |
Why?
|
| Long QT Syndrome | 2 | 2014 | 466 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3803 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2018 | 803 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2012 | 855 | 0.100 |
Why?
|
| Hand Deformities, Congenital | 2 | 2012 | 174 | 0.100 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 107 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2021 | 873 | 0.100 |
Why?
|
| Expressed Sequence Tags | 1 | 2013 | 250 | 0.100 |
Why?
|
| Protein Interaction Mapping | 2 | 2015 | 614 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2013 | 102 | 0.100 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2015 | 284 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2021 | 4575 | 0.100 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2016 | 335 | 0.100 |
Why?
|
| Twins, Monozygotic | 1 | 2014 | 470 | 0.100 |
Why?
|
| Micronesia | 5 | 2010 | 44 | 0.100 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3571 | 0.100 |
Why?
|
| Diarrhea, Infantile | 1 | 2012 | 100 | 0.100 |
Why?
|
| Fetal Hemoglobin | 1 | 2015 | 345 | 0.100 |
Why?
|
| Crosses, Genetic | 9 | 2010 | 752 | 0.100 |
Why?
|
| Introns | 7 | 2015 | 968 | 0.100 |
Why?
|
| Immunity | 1 | 2018 | 996 | 0.100 |
Why?
|
| Alopecia Areata | 1 | 2015 | 128 | 0.100 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2017 | 897 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 3 | 2010 | 174 | 0.100 |
Why?
|
| Siblings | 8 | 2012 | 824 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2017 | 1356 | 0.100 |
Why?
|
| HLA-DQ Antigens | 3 | 2011 | 190 | 0.100 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2013 | 247 | 0.100 |
Why?
|
| Menopause, Premature | 1 | 2013 | 124 | 0.100 |
Why?
|
| Waist-Hip Ratio | 3 | 2020 | 518 | 0.100 |
Why?
|
| DNA Repair | 4 | 2016 | 2041 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 517 | 0.100 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2017 | 307 | 0.100 |
Why?
|
| Fatty Acid Desaturases | 1 | 2012 | 101 | 0.100 |
Why?
|
| Hypoparathyroidism | 1 | 2013 | 136 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 2 | 2014 | 470 | 0.100 |
Why?
|
| Cytosine | 1 | 2013 | 212 | 0.100 |
Why?
|
| Epigenomics | 2 | 2014 | 944 | 0.100 |
Why?
|
| Collagen Type X | 1 | 2011 | 16 | 0.100 |
Why?
|
| Bacillus megaterium | 1 | 2011 | 19 | 0.100 |
Why?
|
| Disease Progression | 5 | 2024 | 13511 | 0.100 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 226 | 0.100 |
Why?
|
| Exercise | 1 | 2008 | 5874 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2813 | 0.100 |
Why?
|
| Behavior | 1 | 2014 | 540 | 0.100 |
Why?
|
| Peroxides | 1 | 1991 | 74 | 0.100 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2021 | 1492 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2015 | 888 | 0.100 |
Why?
|
| Second Messenger Systems | 1 | 2012 | 201 | 0.090 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 548 | 0.090 |
Why?
|
| Prevalence | 9 | 2020 | 15721 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2015 | 270 | 0.090 |
Why?
|
| Interleukin-18 Receptor beta Subunit | 1 | 2011 | 3 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 2008 | 4167 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 1201 | 0.090 |
Why?
|
| Polychondritis, Relapsing | 1 | 2011 | 29 | 0.090 |
Why?
|
| Blood Cells | 1 | 2013 | 306 | 0.090 |
Why?
|
| Colon | 1 | 2019 | 1791 | 0.090 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2011 | 33 | 0.090 |
Why?
|
| Mice, Inbred C3H | 4 | 2008 | 914 | 0.090 |
Why?
|
| Referral and Consultation | 3 | 2017 | 3608 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 15841 | 0.090 |
Why?
|
| Immune System Diseases | 2 | 2013 | 255 | 0.090 |
Why?
|
| Oxidants | 1 | 1991 | 169 | 0.090 |
Why?
|
| DNA Helicases | 1 | 2016 | 850 | 0.090 |
Why?
|
| Optic Disk Drusen | 1 | 2011 | 38 | 0.090 |
Why?
|
| Mycobacterium | 1 | 2012 | 251 | 0.090 |
Why?
|
| Chi-Square Distribution | 4 | 2011 | 3418 | 0.090 |
Why?
|
| Hypobetalipoproteinemias | 1 | 2010 | 11 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1812 | 0.090 |
Why?
|
| Hydro-Lyases | 1 | 2011 | 94 | 0.090 |
Why?
|
| Cluster Analysis | 6 | 2020 | 2706 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 2019 | 0.090 |
Why?
|
| Ataxia | 1 | 2013 | 305 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 934 | 0.090 |
Why?
|
| Software Design | 1 | 2011 | 172 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1048 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2011 | 51 | 0.090 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2012 | 225 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 3 | 2011 | 2164 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2016 | 970 | 0.090 |
Why?
|
| Immune System | 2 | 2013 | 792 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 1668 | 0.090 |
Why?
|
| Melanoma | 3 | 2017 | 5694 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1852 | 0.090 |
Why?
|
| Asthma | 4 | 2023 | 6230 | 0.090 |
Why?
|
| HEK293 Cells | 5 | 2021 | 4243 | 0.090 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2010 | 10 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 918 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2017 | 2489 | 0.090 |
Why?
|
| Angiopoietins | 1 | 2010 | 86 | 0.090 |
Why?
|
| Anorexia Nervosa | 2 | 2017 | 1361 | 0.090 |
Why?
|
| Quebec | 3 | 2005 | 139 | 0.090 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 433 | 0.090 |
Why?
|
| Mice, Knockout | 9 | 2017 | 14392 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2138 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2012 | 1912 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2006 | 350 | 0.080 |
Why?
|
| Floxacillin | 1 | 2009 | 3 | 0.080 |
Why?
|
| Polymorphism, Restriction Fragment Length | 6 | 2002 | 765 | 0.080 |
Why?
|
| Epistasis, Genetic | 2 | 2008 | 350 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2014 | 731 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1932 | 0.080 |
Why?
|
| Toluene | 2 | 2000 | 32 | 0.080 |
Why?
|
| Sterols | 1 | 2009 | 64 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2007 | 127 | 0.080 |
Why?
|
| Complement C7 | 1 | 2009 | 15 | 0.080 |
Why?
|
| Arginine | 2 | 2010 | 920 | 0.080 |
Why?
|
| Blood Platelet Disorders | 1 | 2010 | 60 | 0.080 |
Why?
|
| HeLa Cells | 5 | 2016 | 3073 | 0.080 |
Why?
|
| Electron Transport Complex I | 1 | 2010 | 153 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2015 | 862 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2018 | 1545 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2896 | 0.080 |
Why?
|
| Receptors, GABA-A | 2 | 2020 | 621 | 0.080 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2010 | 284 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2018 | 1057 | 0.080 |
Why?
|
| Genes, Dominant | 4 | 2015 | 850 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 453 | 0.080 |
Why?
|
| Follow-Up Studies | 8 | 2024 | 39127 | 0.080 |
Why?
|
| Models, Biological | 4 | 2011 | 9458 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 150 | 0.080 |
Why?
|
| Cadherins | 2 | 2010 | 902 | 0.080 |
Why?
|
| Androgens | 1 | 2016 | 1283 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3596 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2008 | 60 | 0.080 |
Why?
|
| Information Management | 1 | 2009 | 100 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 480 | 0.080 |
Why?
|
| Synapses | 2 | 2016 | 1755 | 0.080 |
Why?
|
| Dogs | 2 | 2005 | 3832 | 0.080 |
Why?
|
| Ankyrins | 1 | 2008 | 123 | 0.080 |
Why?
|
| North America | 3 | 2020 | 1284 | 0.080 |
Why?
|
| Leuprolide | 4 | 1994 | 312 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 255 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2455 | 0.080 |
Why?
|
| Signal Transduction | 13 | 2023 | 23419 | 0.080 |
Why?
|
| Genes, Bacterial | 4 | 2001 | 1073 | 0.080 |
Why?
|
| Time Factors | 13 | 2020 | 39957 | 0.080 |
Why?
|
| Myosin Type V | 1 | 2008 | 32 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2012 | 790 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 731 | 0.080 |
Why?
|
| Infant | 13 | 2024 | 36170 | 0.070 |
Why?
|
| Germany | 3 | 2019 | 872 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 3390 | 0.070 |
Why?
|
| Vasodilation | 1 | 2012 | 966 | 0.070 |
Why?
|
| Antigens, CD | 4 | 2017 | 4009 | 0.070 |
Why?
|
| Bacteria | 1 | 2019 | 2190 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 731 | 0.070 |
Why?
|
| Rats | 12 | 2012 | 23705 | 0.070 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2007 | 50 | 0.070 |
Why?
|
| Zea mays | 1 | 2008 | 110 | 0.070 |
Why?
|
| Body Mass Index | 8 | 2022 | 12952 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2012 | 1867 | 0.070 |
Why?
|
| Stomach | 2 | 2011 | 697 | 0.070 |
Why?
|
| Eye Proteins | 2 | 2021 | 632 | 0.070 |
Why?
|
| Trans-Activators | 3 | 2007 | 2846 | 0.070 |
Why?
|
| Renin-Angiotensin System | 1 | 2012 | 735 | 0.070 |
Why?
|
| Models, Molecular | 5 | 2020 | 5406 | 0.070 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2007 | 415 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2017 | 1579 | 0.070 |
Why?
|
| Th17 Cells | 3 | 2022 | 794 | 0.070 |
Why?
|
| Parkinson Disease | 2 | 2020 | 2867 | 0.070 |
Why?
|
| Myocardial Infarction | 4 | 2017 | 11476 | 0.070 |
Why?
|
| Educational Status | 3 | 2021 | 2510 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2021 | 47 | 0.070 |
Why?
|
| Ion Transport | 1 | 2008 | 319 | 0.070 |
Why?
|
| Thrombosis | 2 | 2024 | 2944 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2007 | 88 | 0.070 |
Why?
|
| Glycoproteins | 2 | 2021 | 2203 | 0.070 |
Why?
|
| Parthenogenesis | 1 | 2006 | 30 | 0.070 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2021 | 71 | 0.070 |
Why?
|
| DNA Methylation | 3 | 2020 | 4384 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2585 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2017 | 5809 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 2330 | 0.070 |
Why?
|
| Deafness | 1 | 2011 | 460 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2007 | 92 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2024 | 4822 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2015 | 3417 | 0.070 |
Why?
|
| Endopeptidases | 1 | 1990 | 766 | 0.070 |
Why?
|
| Hypogonadism | 1 | 2013 | 798 | 0.070 |
Why?
|
| Homeodomain Proteins | 3 | 2021 | 2414 | 0.070 |
Why?
|
| Cells, Cultured | 10 | 2016 | 18927 | 0.070 |
Why?
|
| Chromosome Segregation | 2 | 2024 | 235 | 0.070 |
Why?
|
| Glucokinase | 1 | 2007 | 102 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2013 | 1145 | 0.070 |
Why?
|
| Mitochondrial Diseases | 1 | 2010 | 342 | 0.070 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 1246 | 0.070 |
Why?
|
| Rats, Inbred Strains | 5 | 1996 | 2087 | 0.070 |
Why?
|
| Medical History Taking | 2 | 2008 | 773 | 0.070 |
Why?
|
| Subtraction Technique | 1 | 2009 | 518 | 0.070 |
Why?
|
| Incidence | 7 | 2024 | 21366 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2006 | 61 | 0.070 |
Why?
|
| Comorbidity | 5 | 2022 | 10516 | 0.070 |
Why?
|
| Biometry | 2 | 2008 | 563 | 0.070 |
Why?
|
| Prognosis | 8 | 2020 | 29688 | 0.070 |
Why?
|
| Family Relations | 1 | 2008 | 317 | 0.070 |
Why?
|
| Cystic Fibrosis | 2 | 2002 | 1283 | 0.070 |
Why?
|
| DNA, Bacterial | 4 | 2019 | 1470 | 0.070 |
Why?
|
| H-2 Antigens | 1 | 2006 | 358 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 403 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 2 | 2020 | 420 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 138 | 0.070 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 480 | 0.070 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2007 | 262 | 0.070 |
Why?
|
| Hot Temperature | 2 | 2011 | 1434 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 2 | 2000 | 826 | 0.070 |
Why?
|
| Information Services | 1 | 2007 | 236 | 0.070 |
Why?
|
| Osteochondrodysplasias | 2 | 2000 | 182 | 0.070 |
Why?
|
| Adiponectin | 1 | 2012 | 1107 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2021 | 1963 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 3 | 2017 | 929 | 0.070 |
Why?
|
| Insulysin | 1 | 2006 | 49 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 1423 | 0.060 |
Why?
|
| Matched-Pair Analysis | 4 | 2000 | 284 | 0.060 |
Why?
|
| Coronary Disease | 4 | 2017 | 5921 | 0.060 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2006 | 201 | 0.060 |
Why?
|
| Sex Factors | 5 | 2020 | 10553 | 0.060 |
Why?
|
| Frontal Sinus | 1 | 2005 | 51 | 0.060 |
Why?
|
| Arthritis | 1 | 2011 | 681 | 0.060 |
Why?
|
| Plasmids | 5 | 2006 | 2261 | 0.060 |
Why?
|
| Histocompatibility | 1 | 2006 | 319 | 0.060 |
Why?
|
| Gene Library | 2 | 2023 | 1054 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 872 | 0.060 |
Why?
|
| Orientation | 1 | 2007 | 320 | 0.060 |
Why?
|
| Glycosylation | 2 | 2020 | 1095 | 0.060 |
Why?
|
| Turner Syndrome | 1 | 2006 | 129 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 2054 | 0.060 |
Why?
|
| X Chromosome | 3 | 2012 | 816 | 0.060 |
Why?
|
| Frontal Bone | 1 | 2005 | 105 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2011 | 1553 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 5 | 2013 | 6200 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2009 | 1221 | 0.060 |
Why?
|
| Protein Binding | 6 | 2017 | 9297 | 0.060 |
Why?
|
| Glucose | 4 | 2018 | 4342 | 0.060 |
Why?
|
| Ozone | 2 | 1999 | 482 | 0.060 |
Why?
|
| Organizational Case Studies | 1 | 2006 | 301 | 0.060 |
Why?
|
| Macrophages | 4 | 2021 | 5755 | 0.060 |
Why?
|
| Contracture | 1 | 1987 | 235 | 0.060 |
Why?
|
| Diabetes Mellitus | 3 | 2017 | 5842 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 489 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2024 | 68 | 0.060 |
Why?
|
| Patient Education as Topic | 2 | 2008 | 2317 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2008 | 865 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2008 | 1577 | 0.060 |
Why?
|
| Statistics, Nonparametric | 4 | 2012 | 2854 | 0.060 |
Why?
|
| Binding Sites | 3 | 2018 | 5988 | 0.060 |
Why?
|
| Arabidopsis | 1 | 2008 | 466 | 0.060 |
Why?
|
| Breast Neoplasms, Male | 2 | 1996 | 212 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 135 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2013 | 1589 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2010 | 3155 | 0.060 |
Why?
|
| Antigens, Surface | 3 | 2022 | 1607 | 0.060 |
Why?
|
| Leiomyoma | 3 | 1994 | 636 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2022 | 2478 | 0.060 |
Why?
|
| Steroids | 1 | 2009 | 929 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2016 | 4052 | 0.060 |
Why?
|
| Placenta | 2 | 2024 | 1711 | 0.060 |
Why?
|
| Cytokines | 4 | 2020 | 7386 | 0.060 |
Why?
|
| Uterine Neoplasms | 4 | 1994 | 1420 | 0.060 |
Why?
|
| Receptors, Drug | 1 | 2004 | 157 | 0.060 |
Why?
|
| Hospitalization | 1 | 2024 | 10707 | 0.060 |
Why?
|
| Cognition | 4 | 2023 | 6988 | 0.060 |
Why?
|
| P-Selectin | 2 | 2011 | 599 | 0.060 |
Why?
|
| Programming Languages | 1 | 2004 | 130 | 0.060 |
Why?
|
| Mice, Congenic | 3 | 2008 | 97 | 0.060 |
Why?
|
| Tuberculosis | 2 | 2008 | 2017 | 0.060 |
Why?
|
| Depressive Disorder, Major | 4 | 2019 | 4767 | 0.060 |
Why?
|
| alpha-Macroglobulins | 1 | 2003 | 60 | 0.060 |
Why?
|
| Pregnancy | 6 | 2024 | 29893 | 0.060 |
Why?
|
| Actomyosin | 1 | 2024 | 109 | 0.060 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2023 | 12 | 0.060 |
Why?
|
| Myocytes, Cardiac | 2 | 2024 | 1666 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2014 | 2740 | 0.060 |
Why?
|
| Russia | 1 | 2024 | 383 | 0.060 |
Why?
|
| Infectious Mononucleosis | 1 | 2024 | 133 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 84 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 5775 | 0.050 |
Why?
|
| Prions | 2 | 2016 | 177 | 0.050 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2006 | 229 | 0.050 |
Why?
|
| Lichen Planus | 1 | 2024 | 70 | 0.050 |
Why?
|
| Hippocampus | 1 | 2016 | 3754 | 0.050 |
Why?
|
| Fibronectins | 1 | 2007 | 724 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 2247 | 0.050 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2003 | 74 | 0.050 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2004 | 144 | 0.050 |
Why?
|
| von Willebrand Factor | 2 | 2000 | 677 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2009 | 1008 | 0.050 |
Why?
|
| Reoperation | 1 | 2014 | 4303 | 0.050 |
Why?
|
| Forecasting | 1 | 2012 | 2928 | 0.050 |
Why?
|
| Reference Values | 5 | 2008 | 4921 | 0.050 |
Why?
|
| Th2 Cells | 2 | 2000 | 1071 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3354 | 0.050 |
Why?
|
| Mice, Mutant Strains | 3 | 2018 | 1751 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 585 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1336 | 0.050 |
Why?
|
| Ethosuximide | 1 | 1982 | 9 | 0.050 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 993 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2005 | 524 | 0.050 |
Why?
|
| Estonia | 1 | 2023 | 56 | 0.050 |
Why?
|
| Genome, Plant | 1 | 2023 | 82 | 0.050 |
Why?
|
| Chromosomes, Human, Y | 1 | 2024 | 161 | 0.050 |
Why?
|
| Albinism | 1 | 2002 | 25 | 0.050 |
Why?
|
| Sloths | 1 | 2022 | 3 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 456 | 0.050 |
Why?
|
| Biological Evolution | 3 | 2005 | 1075 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1602 | 0.050 |
Why?
|
| Genes, p16 | 1 | 2003 | 160 | 0.050 |
Why?
|
| Neurofibroma | 1 | 2003 | 95 | 0.050 |
Why?
|
| Neck | 1 | 2007 | 734 | 0.050 |
Why?
|
| Centrosome | 1 | 2024 | 209 | 0.050 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 4673 | 0.050 |
Why?
|
| Africa, Southern | 1 | 2022 | 60 | 0.050 |
Why?
|
| Monophenol Monooxygenase | 1 | 2002 | 72 | 0.050 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 18222 | 0.050 |
Why?
|
| Epilepsy, Absence | 1 | 1982 | 49 | 0.050 |
Why?
|
| Selection Bias | 2 | 2002 | 359 | 0.050 |
Why?
|
| Albuminuria | 2 | 2014 | 656 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 2 | 2024 | 1076 | 0.050 |
Why?
|
| F-Box Proteins | 1 | 2024 | 200 | 0.050 |
Why?
|
| Antithrombins | 2 | 1998 | 294 | 0.050 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2012 | 1390 | 0.050 |
Why?
|
| Genes, abl | 1 | 2002 | 69 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 665 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2009 | 2667 | 0.050 |
Why?
|
| Operon | 2 | 2001 | 372 | 0.050 |
Why?
|
| Drosophila melanogaster | 3 | 2006 | 1716 | 0.050 |
Why?
|
| Arabs | 1 | 2004 | 187 | 0.050 |
Why?
|
| RNA Interference | 4 | 2018 | 2816 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2004 | 554 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 4 | 1999 | 418 | 0.050 |
Why?
|
| Diabetic Retinopathy | 1 | 2011 | 1276 | 0.050 |
Why?
|
| Butyrate Response Factor 1 | 1 | 2021 | 10 | 0.050 |
Why?
|
| Burkholderia cepacia | 1 | 2002 | 22 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2009 | 1122 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2008 | 944 | 0.050 |
Why?
|
| Organizational Culture | 1 | 2006 | 509 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2009 | 1891 | 0.050 |
Why?
|
| Internationality | 3 | 2014 | 999 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2021 | 1334 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2426 | 0.050 |
Why?
|
| Histones | 3 | 2018 | 2570 | 0.050 |
Why?
|
| Life Style | 3 | 2012 | 3907 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2010 | 2475 | 0.050 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2021 | 68 | 0.050 |
Why?
|
| Succimer | 1 | 1981 | 31 | 0.050 |
Why?
|
| Plasmacytoma | 1 | 2002 | 171 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 162 | 0.050 |
Why?
|
| Head | 1 | 2007 | 922 | 0.050 |
Why?
|
| Burkholderia Infections | 1 | 2002 | 41 | 0.050 |
Why?
|
| DNA, Ribosomal | 2 | 2019 | 298 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 918 | 0.050 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 544 | 0.050 |
Why?
|
| Receptors, Virus | 2 | 2020 | 642 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2021 | 48 | 0.050 |
Why?
|
| Gene Conversion | 1 | 2001 | 67 | 0.050 |
Why?
|
| Estrogen Antagonists | 2 | 1998 | 150 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2024 | 705 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2006 | 1682 | 0.050 |
Why?
|
| Clostridium | 1 | 2001 | 100 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2020 | 2549 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2003 | 495 | 0.050 |
Why?
|
| Portugal | 3 | 2005 | 91 | 0.050 |
Why?
|
| Technetium | 1 | 1981 | 326 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 1168 | 0.050 |
Why?
|
| Paired Box Transcription Factors | 1 | 2021 | 206 | 0.050 |
Why?
|
| Chromosome Inversion | 2 | 2012 | 119 | 0.050 |
Why?
|
| Reference Standards | 2 | 2020 | 1005 | 0.050 |
Why?
|
| Serpin E2 | 1 | 2020 | 48 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 1132 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2007 | 1500 | 0.040 |
Why?
|
| Weibel-Palade Bodies | 1 | 2000 | 19 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 15308 | 0.040 |
Why?
|
| Access to Information | 1 | 2023 | 316 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3446 | 0.040 |
Why?
|
| Glucose Tolerance Test | 3 | 2012 | 1178 | 0.040 |
Why?
|
| Ireland | 3 | 2008 | 169 | 0.040 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 132 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2007 | 2257 | 0.040 |
Why?
|
| Glycerol Kinase | 1 | 2000 | 17 | 0.040 |
Why?
|
| Counseling | 1 | 2008 | 1536 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 830 | 0.040 |
Why?
|
| Cell Differentiation | 5 | 2023 | 11512 | 0.040 |
Why?
|
| United States | 13 | 2020 | 72341 | 0.040 |
Why?
|
| Thyroglobulin | 1 | 2020 | 111 | 0.040 |
Why?
|
| Goiter | 1 | 2020 | 87 | 0.040 |
Why?
|
| Sweden | 3 | 2012 | 1379 | 0.040 |
Why?
|
| Antiporters | 2 | 2007 | 276 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2020 | 64 | 0.040 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2020 | 82 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3493 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2014 | 5032 | 0.040 |
Why?
|
| Transformation, Bacterial | 1 | 2000 | 76 | 0.040 |
Why?
|
| Th1 Cells | 2 | 2013 | 1042 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 5145 | 0.040 |
Why?
|
| Electrocardiography | 2 | 2014 | 6387 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1985 | 0.040 |
Why?
|
| Valproic Acid | 1 | 1982 | 443 | 0.040 |
Why?
|
| Contig Mapping | 1 | 1999 | 54 | 0.040 |
Why?
|
| Leigh Disease | 1 | 2001 | 89 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2006 | 794 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 1981 | 296 | 0.040 |
Why?
|
| Serotonin Antagonists | 1 | 2000 | 144 | 0.040 |
Why?
|
| Limb Deformities, Congenital | 1 | 2000 | 136 | 0.040 |
Why?
|
| Ganglioglioma | 1 | 2019 | 36 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 3778 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 151 | 0.040 |
Why?
|
| Ileum | 1 | 2022 | 557 | 0.040 |
Why?
|
| CpG Islands | 3 | 2016 | 1190 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2002 | 958 | 0.040 |
Why?
|
| Eye | 1 | 2023 | 713 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 1129 | 0.040 |
Why?
|
| Ondansetron | 1 | 2000 | 95 | 0.040 |
Why?
|
| Protein Array Analysis | 2 | 2016 | 399 | 0.040 |
Why?
|
| Population Growth | 1 | 2019 | 50 | 0.040 |
Why?
|
| Drosophila Proteins | 2 | 2006 | 1702 | 0.040 |
Why?
|
| CRADD Signaling Adaptor Protein | 1 | 2019 | 6 | 0.040 |
Why?
|
| Pseudogenes | 2 | 2002 | 104 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2006 | 830 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2019 | 7965 | 0.040 |
Why?
|
| Japan | 2 | 2020 | 1378 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2019 | 1936 | 0.040 |
Why?
|
| Immunogenetics | 1 | 2019 | 62 | 0.040 |
Why?
|
| Monocytes | 2 | 2020 | 2570 | 0.040 |
Why?
|
| Antigens, CD19 | 2 | 2015 | 424 | 0.040 |
Why?
|
| Myeloma Proteins | 1 | 1999 | 71 | 0.040 |
Why?
|
| Iceland | 1 | 2019 | 184 | 0.040 |
Why?
|
| Trichloroethylene | 1 | 1998 | 13 | 0.040 |
Why?
|
| Dyspepsia | 1 | 2000 | 116 | 0.040 |
Why?
|
| Ions | 1 | 2000 | 255 | 0.040 |
Why?
|
| Glycomics | 1 | 2020 | 113 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4567 | 0.040 |
Why?
|
| Parents | 3 | 2021 | 3564 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2021 | 381 | 0.040 |
Why?
|
| Biological Transport | 3 | 2013 | 2081 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1999 | 849 | 0.040 |
Why?
|
| DNA Primers | 7 | 1996 | 2814 | 0.040 |
Why?
|
| Glycerol | 1 | 2000 | 275 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 210 | 0.040 |
Why?
|
| Lipoproteins, HDL | 2 | 2020 | 675 | 0.040 |
Why?
|
| Norway | 1 | 2020 | 499 | 0.040 |
Why?
|
| Bacterial Proteins | 5 | 2011 | 3836 | 0.040 |
Why?
|
| Translocation, Genetic | 4 | 2012 | 1391 | 0.040 |
Why?
|
| Bone Density | 5 | 2003 | 3546 | 0.040 |
Why?
|
| Thrombospondins | 1 | 2019 | 195 | 0.040 |
Why?
|
| Oxygenases | 1 | 1998 | 59 | 0.040 |
Why?
|
| Radiology | 2 | 2009 | 2112 | 0.040 |
Why?
|
| Role | 1 | 1999 | 176 | 0.040 |
Why?
|
| Dementia | 1 | 2013 | 2684 | 0.040 |
Why?
|
| Italy | 2 | 2012 | 844 | 0.040 |
Why?
|
| Motivation | 1 | 2008 | 2002 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2001 | 324 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2021 | 850 | 0.040 |
Why?
|
| Paraproteins | 1 | 2018 | 38 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 255 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2019 | 147 | 0.040 |
Why?
|
| Professional Competence | 1 | 2001 | 430 | 0.040 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2001 | 348 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 2000 | 420 | 0.040 |
Why?
|
| Impulsive Behavior | 1 | 2021 | 346 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2018 | 98 | 0.040 |
Why?
|
| Genes, APC | 1 | 1998 | 145 | 0.040 |
Why?
|
| Enterocytes | 1 | 2019 | 220 | 0.040 |
Why?
|
| Food Preservation | 1 | 1997 | 13 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 9025 | 0.040 |
Why?
|
| Treatment Outcome | 8 | 2024 | 64681 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 323 | 0.040 |
Why?
|
| Fear | 1 | 2006 | 1477 | 0.040 |
Why?
|
| Endemic Diseases | 1 | 1999 | 191 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2010 | 2468 | 0.040 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 10203 | 0.040 |
Why?
|
| Automation | 1 | 2020 | 585 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2024 | 3091 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 374 | 0.040 |
Why?
|
| Neuregulins | 1 | 2017 | 36 | 0.040 |
Why?
|
| Food Microbiology | 1 | 1997 | 74 | 0.040 |
Why?
|
| Domestic Violence | 1 | 1999 | 180 | 0.040 |
Why?
|
| Australia | 3 | 2008 | 1246 | 0.040 |
Why?
|
| Medical Errors | 1 | 2006 | 1263 | 0.040 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1997 | 107 | 0.040 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2018 | 133 | 0.040 |
Why?
|
| Dendritic Cells | 2 | 2021 | 2726 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 2017 | 53 | 0.040 |
Why?
|
| Heart Rate | 1 | 2009 | 4197 | 0.040 |
Why?
|
| Americas | 1 | 2017 | 110 | 0.040 |
Why?
|
| Kidney | 3 | 2016 | 7033 | 0.040 |
Why?
|
| Syndactyly | 1 | 1997 | 74 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 363 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 14675 | 0.030 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.030 |
Why?
|
| Attention | 1 | 2007 | 2394 | 0.030 |
Why?
|
| Poland | 2 | 2007 | 198 | 0.030 |
Why?
|
| Pruritus | 1 | 2000 | 378 | 0.030 |
Why?
|
| Metagenomics | 1 | 2020 | 463 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 303 | 0.030 |
Why?
|
| Artifacts | 2 | 2020 | 1912 | 0.030 |
Why?
|
| Mississippi | 1 | 2016 | 94 | 0.030 |
Why?
|
| Fenofibrate | 1 | 2016 | 87 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1999 | 292 | 0.030 |
Why?
|
| Infant, Newborn | 6 | 2016 | 26200 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2016 | 125 | 0.030 |
Why?
|
| Lysine | 2 | 2015 | 982 | 0.030 |
Why?
|
| Rats, Mutant Strains | 1 | 1996 | 60 | 0.030 |
Why?
|
| Health Promotion | 1 | 2008 | 2205 | 0.030 |
Why?
|
| Population Dynamics | 2 | 2008 | 308 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2010 | 127 | 0.030 |
Why?
|
| Pakistan | 1 | 2017 | 292 | 0.030 |
Why?
|
| Complement Pathway, Classical | 1 | 2016 | 91 | 0.030 |
Why?
|
| Parkinsonian Disorders | 1 | 2019 | 285 | 0.030 |
Why?
|
| Leukemia | 1 | 2024 | 1518 | 0.030 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1997 | 271 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2004 | 1356 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2016 | 198 | 0.030 |
Why?
|
| Gastric Acid | 2 | 1986 | 99 | 0.030 |
Why?
|
| Age Factors | 4 | 2020 | 18384 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2000 | 4201 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2000 | 575 | 0.030 |
Why?
|
| Ubiquitin | 2 | 2012 | 839 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 329 | 0.030 |
Why?
|
| Gene Amplification | 2 | 2010 | 1084 | 0.030 |
Why?
|
| Diabetic Nephropathies | 2 | 2014 | 973 | 0.030 |
Why?
|
| Endoscopy | 1 | 2005 | 1852 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2015 | 28 | 0.030 |
Why?
|
| Apolipoprotein C-III | 1 | 2017 | 210 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 504 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3758 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 1998 | 410 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 221 | 0.030 |
Why?
|
| Sertraline | 1 | 2016 | 209 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2003 | 396 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 874 | 0.030 |
Why?
|
| Diet | 2 | 2012 | 8048 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 4744 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 481 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2001 | 1141 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 12474 | 0.030 |
Why?
|
| Kinetics | 2 | 2014 | 6312 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 2001 | 1505 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 2894 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 1997 | 346 | 0.030 |
Why?
|
| Video Recording | 1 | 2000 | 965 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2018 | 2916 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3412 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2018 | 4111 | 0.030 |
Why?
|
| Phagosomes | 1 | 2016 | 199 | 0.030 |
Why?
|
| Nipples | 1 | 1997 | 229 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2019 | 1597 | 0.030 |
Why?
|
| Sex Offenses | 1 | 1999 | 352 | 0.030 |
Why?
|
| Cholesterol | 2 | 2021 | 2902 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 370 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 1111 | 0.030 |
Why?
|
| Zinc Fingers | 2 | 2000 | 575 | 0.030 |
Why?
|
| Blood Pressure | 4 | 2016 | 8479 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2021 | 1607 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 1855 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2018 | 597 | 0.030 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2015 | 141 | 0.030 |
Why?
|
| Ciliary Body | 1 | 2015 | 168 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 4574 | 0.030 |
Why?
|
| Complement C3b | 1 | 2014 | 98 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 4947 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2015 | 790 | 0.030 |
Why?
|
| Aorta | 1 | 2022 | 2040 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1999 | 617 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1988 | 2561 | 0.030 |
Why?
|
| Income | 1 | 2023 | 1869 | 0.030 |
Why?
|
| Metagenome | 1 | 2018 | 447 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 7407 | 0.030 |
Why?
|
| Models, Animal | 2 | 2016 | 2114 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2016 | 8642 | 0.030 |
Why?
|
| Twins | 1 | 2015 | 340 | 0.030 |
Why?
|
| Adipokines | 1 | 2016 | 307 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3245 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 2478 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3552 | 0.030 |
Why?
|
| Germ Cells | 1 | 2018 | 632 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2017 | 696 | 0.030 |
Why?
|
| Interferons | 1 | 2017 | 702 | 0.030 |
Why?
|
| Mice, Inbred A | 2 | 2008 | 245 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2007 | 557 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 2 | 2009 | 877 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2019 | 869 | 0.030 |
Why?
|
| Tamoxifen | 1 | 1998 | 965 | 0.030 |
Why?
|
| Eosinophilia | 1 | 1998 | 557 | 0.030 |
Why?
|
| Collagen | 1 | 2022 | 2635 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2017 | 2549 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2000 | 1316 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 1876 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2000 | 2227 | 0.030 |
Why?
|
| Smoking | 3 | 2019 | 9055 | 0.030 |
Why?
|
| Education | 1 | 2016 | 536 | 0.030 |
Why?
|
| Population Control | 1 | 2013 | 22 | 0.030 |
Why?
|
| Sulfates | 1 | 1994 | 378 | 0.030 |
Why?
|
| DNA Damage | 3 | 1999 | 2443 | 0.030 |
Why?
|
| Gliosis | 1 | 2014 | 245 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2000 | 883 | 0.030 |
Why?
|
| Amidine-Lyases | 1 | 2012 | 4 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 1140 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2007 | 20588 | 0.030 |
Why?
|
| Probability | 2 | 2008 | 2478 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2002 | 781 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2019 | 913 | 0.030 |
Why?
|
| Dendrites | 1 | 2016 | 471 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1999 | 662 | 0.030 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2012 | 33 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 2010 | 1067 | 0.030 |
Why?
|
| Hybridization, Genetic | 2 | 2005 | 102 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1892 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 1464 | 0.030 |
Why?
|
| Survival Analysis | 4 | 2015 | 10088 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2013 | 115 | 0.030 |
Why?
|
| Prospective Studies | 9 | 2012 | 54437 | 0.030 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 1997 | 380 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2018 | 1169 | 0.030 |
Why?
|
| Myoma | 1 | 1992 | 6 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 1070 | 0.030 |
Why?
|
| Canada | 2 | 2013 | 2125 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1997 | 833 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2000 | 1873 | 0.030 |
Why?
|
| Proinsulin | 1 | 2012 | 135 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 1997 | 747 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 8998 | 0.030 |
Why?
|
| Croatia | 1 | 2012 | 34 | 0.030 |
Why?
|
| Organic Anion Transporters | 1 | 2013 | 101 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 763 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 3057 | 0.030 |
Why?
|
| Autoantigens | 1 | 2016 | 888 | 0.030 |
Why?
|
| Aquaporins | 1 | 2013 | 174 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1331 | 0.030 |
Why?
|
| Phylogeography | 1 | 2012 | 72 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2709 | 0.030 |
Why?
|
| Mice, Inbred CBA | 2 | 2006 | 438 | 0.030 |
Why?
|
| Communication | 2 | 1999 | 3872 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 927 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2016 | 609 | 0.020 |
Why?
|
| Microfilament Proteins | 2 | 2014 | 1130 | 0.020 |
Why?
|
| Scotland | 1 | 2012 | 143 | 0.020 |
Why?
|
| Feces | 1 | 2019 | 1490 | 0.020 |
Why?
|
| tert-Butylhydroperoxide | 1 | 1991 | 11 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1993 | 439 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2016 | 730 | 0.020 |
Why?
|
| von Willebrand Diseases | 1 | 1993 | 132 | 0.020 |
Why?
|
| Mycobacterium Infections | 1 | 2012 | 122 | 0.020 |
Why?
|
| Intelligence | 1 | 2017 | 922 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2002 | 8531 | 0.020 |
Why?
|
| Glutamic Acid | 2 | 2004 | 1173 | 0.020 |
Why?
|
| Immunoassay | 1 | 2015 | 743 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5871 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 2635 | 0.020 |
Why?
|
| Uterus | 2 | 1993 | 651 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 2802 | 0.020 |
Why?
|
| Iduronidase | 1 | 2011 | 31 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 3434 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 9520 | 0.020 |
Why?
|
| Neurons | 2 | 2022 | 9429 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2016 | 752 | 0.020 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 1078 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 265 | 0.020 |
Why?
|
| Complement Activation | 1 | 2013 | 445 | 0.020 |
Why?
|
| Calcitriol | 1 | 1993 | 295 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 2 | 2010 | 1603 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2011 | 47 | 0.020 |
Why?
|
| Picolinic Acids | 1 | 2011 | 50 | 0.020 |
Why?
|
| Deferoxamine | 1 | 1991 | 155 | 0.020 |
Why?
|
| Genomic Library | 2 | 2005 | 188 | 0.020 |
Why?
|
| Progestins | 1 | 1993 | 301 | 0.020 |
Why?
|
| Apoptosis | 3 | 2016 | 9478 | 0.020 |
Why?
|
| Proteome | 2 | 2016 | 1856 | 0.020 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2011 | 53 | 0.020 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 1869 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1085 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2014 | 298 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2012 | 395 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2011 | 113 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2013 | 356 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 1126 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3369 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2015 | 707 | 0.020 |
Why?
|
| Speech Recognition Software | 1 | 2011 | 74 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 579 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4321 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1958 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2003 | 8002 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2017 | 1330 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2000 | 1796 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 34 | 0.020 |
Why?
|
| Statistics as Topic | 3 | 2006 | 2359 | 0.020 |
Why?
|
| Parathyroid Hormone | 3 | 1993 | 1803 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 982 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 416 | 0.020 |
Why?
|
| ROC Curve | 2 | 2008 | 3584 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1992 | 249 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2010 | 102 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2277 | 0.020 |
Why?
|
| Alkalosis | 1 | 1990 | 55 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2005 | 1226 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 988 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1998 | 1520 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2014 | 962 | 0.020 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2010 | 82 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3388 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 634 | 0.020 |
Why?
|
| Hyperparathyroidism | 1 | 1991 | 337 | 0.020 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2011 | 132 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1996 | 808 | 0.020 |
Why?
|
| Renin | 1 | 2012 | 639 | 0.020 |
Why?
|
| Fruit | 1 | 1995 | 1158 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 139 | 0.020 |
Why?
|
| Meiosis | 2 | 2006 | 327 | 0.020 |
Why?
|
| tau Proteins | 1 | 2020 | 2094 | 0.020 |
Why?
|
| Phytosterols | 1 | 2009 | 55 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2009 | 101 | 0.020 |
Why?
|
| Homeostasis | 1 | 2020 | 3322 | 0.020 |
Why?
|
| Liver | 2 | 2020 | 7512 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 974 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2010 | 212 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2024 | 9319 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2009 | 52 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2013 | 709 | 0.020 |
Why?
|
| Glutamates | 1 | 1990 | 385 | 0.020 |
Why?
|
| Complement C2 | 1 | 2008 | 45 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 1993 | 908 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2010 | 115 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1895 | 0.020 |
Why?
|
| Semaphorins | 1 | 2009 | 96 | 0.020 |
Why?
|
| Time | 1 | 2011 | 545 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 1994 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1999 | 1910 | 0.020 |
Why?
|
| Karyotyping | 1 | 2011 | 1172 | 0.020 |
Why?
|
| Complement Factor B | 1 | 2008 | 57 | 0.020 |
Why?
|
| Valine | 1 | 1990 | 408 | 0.020 |
Why?
|
| Parity | 2 | 2004 | 929 | 0.020 |
Why?
|
| Heparin | 2 | 1998 | 1632 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 545 | 0.020 |
Why?
|
| Patient Satisfaction | 2 | 2000 | 3453 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 1012 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 1990 | 339 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1495 | 0.020 |
Why?
|
| DNA, Neoplasm | 4 | 1997 | 1743 | 0.020 |
Why?
|
| Research Design | 1 | 2004 | 6180 | 0.020 |
Why?
|
| Equipment Design | 2 | 2007 | 3510 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 590 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2019 | 2598 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2452 | 0.020 |
Why?
|
| Survival Rate | 2 | 2017 | 12728 | 0.020 |
Why?
|
| Saccharin | 1 | 2008 | 20 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2010 | 446 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2009 | 240 | 0.020 |
Why?
|
| Ploidies | 2 | 2000 | 285 | 0.020 |
Why?
|
| Linguistics | 1 | 2008 | 108 | 0.020 |
Why?
|
| Flowers | 1 | 2008 | 31 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 410 | 0.020 |
Why?
|
| Glycine | 2 | 2004 | 659 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2009 | 199 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2011 | 351 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 1991 | 1988 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 197 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2018 | 2335 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
| Acidosis | 1 | 1990 | 269 | 0.020 |
Why?
|
| Diacetyl | 1 | 1987 | 21 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 16954 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1838 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1160 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1186 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 1671 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 1002 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3620 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1999 | 2515 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2013 | 3092 | 0.020 |
Why?
|
| Immunoelectrophoresis | 1 | 1987 | 94 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 10756 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 1967 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2009 | 256 | 0.020 |
Why?
|
| Body Weight | 2 | 2008 | 4618 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1885 | 0.020 |
Why?
|
| Isoantigens | 1 | 1990 | 559 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 314 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 4373 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1999 | 2527 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1432 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1993 | 1146 | 0.020 |
Why?
|
| Social Alienation | 1 | 2006 | 19 | 0.020 |
Why?
|
| Peptides | 2 | 1992 | 4353 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 473 | 0.020 |
Why?
|
| Calmodulin | 1 | 1988 | 217 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12052 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2010 | 659 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2009 | 339 | 0.020 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2008 | 238 | 0.020 |
Why?
|
| Transfection | 2 | 2008 | 5748 | 0.020 |
Why?
|
| Actins | 1 | 2014 | 2046 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 1559 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 1997 | 1741 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 463 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 502 | 0.020 |
Why?
|
| Systems Integration | 1 | 2009 | 428 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 3726 | 0.020 |
Why?
|
| HLA-D Antigens | 1 | 2007 | 130 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1987 | 311 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2010 | 558 | 0.020 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2006 | 59 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2013 | 1416 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 812 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2254 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1987 | 387 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1987 | 659 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2012 | 703 | 0.020 |
Why?
|
| Cross-Sectional Studies | 4 | 2015 | 26072 | 0.020 |
Why?
|
| Perfusion | 2 | 1990 | 1390 | 0.020 |
Why?
|
| Mice, Inbred DBA | 2 | 1997 | 623 | 0.020 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 394 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4537 | 0.020 |
Why?
|
| Sex Characteristics | 2 | 2008 | 2640 | 0.020 |
Why?
|
| Estrogens | 1 | 1993 | 1522 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 938 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2008 | 473 | 0.020 |
Why?
|
| Depression | 2 | 2023 | 8132 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2119 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2006 | 152 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2005 | 41 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2000 | 1989 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5250 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 1560 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 833 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 2005 | 27 | 0.020 |
Why?
|
| Cerebellum | 1 | 2013 | 1501 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 976 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1318 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 1379 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 864 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2009 | 538 | 0.020 |
Why?
|
| Morbidity | 2 | 2002 | 1751 | 0.020 |
Why?
|
| Animals, Congenic | 1 | 2005 | 27 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 174 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 2656 | 0.020 |
Why?
|
| Health Care Costs | 1 | 1999 | 3239 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 1986 | 101 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 459 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2006 | 467 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2006 | 405 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 1301 | 0.020 |
Why?
|
| Testosterone | 1 | 2016 | 2472 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 423 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 96 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 2005 | 221 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2006 | 201 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2005 | 141 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 1768 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 3841 | 0.020 |
Why?
|
| Codon | 1 | 2006 | 597 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 1721 | 0.010 |
Why?
|
| Cricetinae | 1 | 2008 | 2412 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 2746 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2006 | 739 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1728 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2016 | 2893 | 0.010 |
Why?
|
| Azores | 1 | 2004 | 5 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1967 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 1994 | 1658 | 0.010 |
Why?
|
| Glioma | 1 | 2019 | 3452 | 0.010 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2004 | 39 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1999 | 4014 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1993 | 1830 | 0.010 |
Why?
|
| Netherlands | 1 | 2009 | 2222 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2007 | 544 | 0.010 |
Why?
|
| Lung | 2 | 2005 | 9979 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 294 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2007 | 339 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2006 | 390 | 0.010 |
Why?
|
| Space Perception | 1 | 2007 | 465 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 924 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 2 | 2004 | 3590 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2006 | 344 | 0.010 |
Why?
|
| Membrane Transport Proteins | 2 | 2003 | 1031 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 575 | 0.010 |
Why?
|
| Microsomes | 1 | 2003 | 251 | 0.010 |
Why?
|
| Glutamine | 1 | 2006 | 574 | 0.010 |
Why?
|
| Symporters | 1 | 2006 | 363 | 0.010 |
Why?
|
| Wisconsin | 1 | 2003 | 122 | 0.010 |
Why?
|
| Health Surveys | 1 | 2013 | 4037 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1404 | 0.010 |
Why?
|
| Tandem Repeat Sequences | 1 | 2004 | 180 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6486 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 878 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2005 | 247 | 0.010 |
Why?
|
| Remission Induction | 1 | 2009 | 2392 | 0.010 |
Why?
|
| Carcinoma | 1 | 1994 | 2330 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 1990 | 1361 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 1681 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1986 | 603 | 0.010 |
Why?
|
| Clodronic Acid | 1 | 1982 | 58 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6125 | 0.010 |
Why?
|
| Organ Size | 1 | 2008 | 2253 | 0.010 |
Why?
|
| Osteitis Deformans | 1 | 1982 | 54 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2003 | 169 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2008 | 1594 | 0.010 |
Why?
|
| Base Composition | 1 | 2002 | 290 | 0.010 |
Why?
|
| Nerve Net | 1 | 2014 | 2288 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2006 | 597 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 2002 | 101 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 1435 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9187 | 0.010 |
Why?
|
| Carrier State | 1 | 2006 | 522 | 0.010 |
Why?
|
| Radiometry | 1 | 2007 | 812 | 0.010 |
Why?
|
| Fluorouracil | 2 | 1999 | 1642 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 231 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 11101 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 2002 | 223 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2014 | 2056 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2014 | 3813 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 1838 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1624 | 0.010 |
Why?
|
| Iodohippuric Acid | 1 | 1981 | 9 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2011 | 80675 | 0.010 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1982 | 125 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2199 | 0.010 |
Why?
|
| Oocytes | 1 | 2006 | 1165 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2290 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 1008 | 0.010 |
Why?
|
| Alcoholism | 1 | 2012 | 1973 | 0.010 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 1 | 1981 | 81 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 2000 | 13386 | 0.010 |
Why?
|
| Cadaver | 1 | 2005 | 1358 | 0.010 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2001 | 14 | 0.010 |
Why?
|
| Skin | 1 | 2015 | 4473 | 0.010 |
Why?
|
| International Cooperation | 1 | 2007 | 1423 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 2001 | 189 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2001 | 192 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2007 | 1984 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 1610 | 0.010 |
Why?
|
| Foot Deformities, Congenital | 1 | 2000 | 59 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9278 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2003 | 485 | 0.010 |
Why?
|
| Electron Transport Complex IV | 1 | 2001 | 190 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 6504 | 0.010 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2004 | 487 | 0.010 |
Why?
|
| Acute Disease | 2 | 1999 | 7226 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2008 | 1625 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1992 | 775 | 0.010 |
Why?
|
| Thermus | 1 | 1999 | 10 | 0.010 |
Why?
|
| Visual Fields | 1 | 2007 | 1061 | 0.010 |
Why?
|
| Solvents | 1 | 2001 | 294 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 2196 | 0.010 |
Why?
|
| GATA3 Transcription Factor | 1 | 2000 | 155 | 0.010 |
Why?
|
| Calpain | 1 | 2000 | 146 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4420 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5778 | 0.010 |
Why?
|
| Enzymes | 1 | 2001 | 252 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2509 | 0.010 |
Why?
|
| Delayed-Action Preparations | 2 | 1994 | 961 | 0.010 |
Why?
|
| Weight Gain | 1 | 2010 | 2349 | 0.010 |
Why?
|
| Radiography | 2 | 2000 | 6974 | 0.010 |
Why?
|
| Northern Territory | 1 | 1999 | 5 | 0.010 |
Why?
|
| Mothers | 2 | 2000 | 2193 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2005 | 1207 | 0.010 |
Why?
|
| DNA, Circular | 1 | 1999 | 96 | 0.010 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2003 | 410 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 2006 | 5478 | 0.010 |
Why?
|
| Catalase | 1 | 1999 | 217 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 3264 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2002 | 453 | 0.010 |
Why?
|
| Antithrombin Proteins | 1 | 1998 | 10 | 0.010 |
Why?
|
| Psoriasis | 1 | 2007 | 946 | 0.010 |
Why?
|
| Israel | 1 | 2001 | 718 | 0.010 |
Why?
|
| Uremia | 1 | 2000 | 202 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2007 | 2513 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2000 | 1301 | 0.010 |
Why?
|
| Proline | 1 | 2000 | 455 | 0.010 |
Why?
|
| Drosophila | 1 | 2006 | 1499 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2005 | 1230 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 1999 | 3512 | 0.010 |
Why?
|
| North Carolina | 1 | 1999 | 324 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1998 | 241 | 0.010 |
Why?
|
| Computers | 1 | 2001 | 591 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1991 | 862 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1600 | 0.010 |
Why?
|
| Bone and Bones | 2 | 2000 | 2568 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1988 | 1977 | 0.010 |
Why?
|
| Wetting Agents | 1 | 1997 | 2 | 0.010 |
Why?
|
| Glutathione | 1 | 1960 | 581 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1998 | 266 | 0.010 |
Why?
|
| Threonine | 1 | 1998 | 270 | 0.010 |
Why?
|
| Candy | 1 | 1997 | 36 | 0.010 |
Why?
|
| Diphosphonates | 1 | 1982 | 634 | 0.010 |
Why?
|
| Alanine | 1 | 2000 | 608 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2010 | 3422 | 0.010 |
Why?
|
| Fathers | 1 | 2000 | 375 | 0.010 |
Why?
|
| Interleukin-9 | 1 | 1997 | 62 | 0.010 |
Why?
|
| Ectoderm | 1 | 1997 | 137 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 880 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1998 | 425 | 0.010 |
Why?
|
| Family Practice | 1 | 2000 | 507 | 0.010 |
Why?
|
| Meat Products | 1 | 1997 | 96 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2692 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6341 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1981 | 1989 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1999 | 593 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 1997 | 197 | 0.010 |
Why?
|
| Humidity | 1 | 1997 | 205 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2001 | 743 | 0.010 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 1997 | 90 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1998 | 406 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 556 | 0.010 |
Why?
|
| Gastrins | 2 | 1986 | 75 | 0.010 |
Why?
|
| Oxygen | 1 | 1988 | 4228 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 326 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1997 | 281 | 0.010 |
Why?
|
| Gastric Fundus | 2 | 1986 | 37 | 0.010 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1999 | 403 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1981 | 938 | 0.010 |
Why?
|
| China | 1 | 2002 | 2374 | 0.010 |
Why?
|
| Spine | 2 | 1993 | 1129 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 896 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4246 | 0.010 |
Why?
|
| Pancreatitis | 1 | 1982 | 1081 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2000 | 1202 | 0.010 |
Why?
|
| Patient Care Management | 1 | 1999 | 303 | 0.010 |
Why?
|
| Omeprazole | 2 | 1986 | 106 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 646 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2002 | 1936 | 0.010 |
Why?
|
| Reproduction | 1 | 2000 | 646 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 8300 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1995 | 113 | 0.010 |
Why?
|
| Estradiol Congeners | 1 | 1994 | 23 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 1995 | 231 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 1993 | 4851 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1995 | 186 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 421 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1997 | 334 | 0.010 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1994 | 103 | 0.010 |
Why?
|
| Ovariectomy | 1 | 1997 | 614 | 0.010 |
Why?
|
| Alkaline Phosphatase | 2 | 1991 | 859 | 0.010 |
Why?
|
| Norethindrone | 1 | 1994 | 56 | 0.010 |
Why?
|
| Familial Mediterranean Fever | 1 | 1995 | 65 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2002 | 1048 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2001 | 1265 | 0.010 |
Why?
|
| Seafood | 1 | 1997 | 393 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 1996 | 578 | 0.010 |
Why?
|
| Dairy Products | 1 | 1997 | 490 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1999 | 1784 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2000 | 2082 | 0.010 |
Why?
|
| Anion Transport Proteins | 1 | 1994 | 141 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1994 | 11733 | 0.010 |
Why?
|
| DNA Probes | 1 | 1994 | 542 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1993 | 166 | 0.010 |
Why?
|
| Estrone | 1 | 1994 | 234 | 0.010 |
Why?
|
| Spores, Fungal | 1 | 1993 | 90 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1993 | 111 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11067 | 0.010 |
Why?
|
| Hematocrit | 1 | 1994 | 623 | 0.010 |
Why?
|
| RNA, Fungal | 1 | 1993 | 156 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1993 | 6304 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36415 | 0.010 |
Why?
|
| Proteinuria | 1 | 1996 | 605 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1999 | 1468 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 347 | 0.010 |
Why?
|
| Annexins | 1 | 1992 | 38 | 0.010 |
Why?
|
| Recurrence | 2 | 1996 | 8457 | 0.010 |
Why?
|
| Extremities | 1 | 1997 | 867 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 1633 | 0.010 |
Why?
|
| Brain Stem | 1 | 1997 | 858 | 0.010 |
Why?
|
| Colectomy | 1 | 1997 | 686 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1997 | 857 | 0.010 |
Why?
|
| Chromogenic Compounds | 1 | 1991 | 30 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1994 | 8519 | 0.010 |
Why?
|
| Prenatal Care | 1 | 1999 | 1141 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1992 | 224 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 1989 | 5321 | 0.010 |
Why?
|
| Alkalosis, Respiratory | 1 | 1990 | 20 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1981 | 2092 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1545 | 0.010 |
Why?
|
| Acidosis, Respiratory | 1 | 1990 | 37 | 0.010 |
Why?
|
| Buffers | 1 | 1990 | 143 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1990 | 509 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1990 | 261 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1991 | 680 | 0.010 |
Why?
|
| Tretinoin | 1 | 1992 | 517 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1997 | 1807 | 0.000 |
Why?
|
| Colonoscopy | 1 | 1997 | 1395 | 0.000 |
Why?
|
| Hypercalcemia | 1 | 1991 | 423 | 0.000 |
Why?
|
| Mitochondria, Heart | 1 | 1990 | 229 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1999 | 2877 | 0.000 |
Why?
|
| Cisplatin | 1 | 1994 | 1652 | 0.000 |
Why?
|
| Oxidative Stress | 1 | 1999 | 3114 | 0.000 |
Why?
|
| Disease Management | 1 | 1999 | 2507 | 0.000 |
Why?
|
| Cause of Death | 1 | 1998 | 3688 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2000 | 2223 | 0.000 |
Why?
|
| Endometrial Neoplasms | 1 | 1997 | 1366 | 0.000 |
Why?
|
| Kidney Calculi | 1 | 1991 | 463 | 0.000 |
Why?
|
| Pain Measurement | 1 | 1997 | 3549 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1993 | 2048 | 0.000 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 1997 | 1413 | 0.000 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 1997 | 1394 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1997 | 1663 | 0.000 |
Why?
|
| Achlorhydria | 1 | 1986 | 9 | 0.000 |
Why?
|
| Ranitidine | 1 | 1986 | 34 | 0.000 |
Why?
|
| Alcohol Drinking | 1 | 1999 | 4027 | 0.000 |
Why?
|
| Pyloric Antrum | 1 | 1986 | 66 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12341 | 0.000 |
Why?
|
| Child Abuse, Sexual | 1 | 1989 | 403 | 0.000 |
Why?
|
| Creatinine | 1 | 1991 | 1897 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1999 | 5493 | 0.000 |
Why?
|
| Oligopeptides | 1 | 1991 | 1179 | 0.000 |
Why?
|
| Anxiety | 1 | 2000 | 4569 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1999 | 7804 | 0.000 |
Why?
|
| Estradiol | 1 | 1992 | 1937 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1986 | 697 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1981 | 4251 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 11119 | 0.000 |
Why?
|
| Somatostatin | 1 | 1986 | 447 | 0.000 |
Why?
|
| Glucagon | 1 | 1986 | 531 | 0.000 |
Why?
|
| Decision Making | 1 | 1997 | 3931 | 0.000 |
Why?
|
| Hydroxyproline | 1 | 1982 | 110 | 0.000 |
Why?
|
| Adaptation, Psychological | 1 | 1993 | 2632 | 0.000 |
Why?
|
| Substance-Related Disorders | 1 | 1999 | 4413 | 0.000 |
Why?
|
| Cell Division | 1 | 1990 | 4451 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1982 | 275 | 0.000 |
Why?
|
| Wound Infection | 1 | 1964 | 244 | 0.000 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1990 | 1803 | 0.000 |
Why?
|
| Gastrectomy | 1 | 1986 | 672 | 0.000 |
Why?
|
| Benzimidazoles | 1 | 1986 | 858 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1993 | 5969 | 0.000 |
Why?
|
| Health Personnel | 1 | 1993 | 3337 | 0.000 |
Why?
|
| Quality of Life | 1 | 1998 | 13367 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1964 | 1401 | 0.000 |
Why?
|
| Cross Infection | 1 | 1964 | 1422 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1997 | 13632 | 0.000 |
Why?
|
| Pennsylvania | 1 | 1964 | 612 | 0.000 |
Why?
|